Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.81 USD | 0.00% |
|
-4.13% | -8.95% |
05-14 | Cantor Fitzgerald Adjusts Price Target on Exagen to $7 From $5, Maintains Overweight Rating | MT |
05-13 | Exagen Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.95% | 31.45M | |
+17.21% | 82.53B | |
-26.74% | 73B | |
-1.13% | 26.4B | |
-10.93% | 17.12B | |
+0.78% | 17.09B | |
-0.48% | 15.23B | |
+73.40% | 13.24B | |
+77.31% | 13.02B | |
-25.09% | 12.82B |
- Stock Market
- Equities
- XGN Stock
- News Exagen Inc.
- Earnings Flash (XGN) EXAGEN Reports Q3 Revenue $13.4M, vs. Street Est of $10.3M